ClinicalTrialsFinder

Relapsed B-Cell Non Hodgkin Lymphoma Clinical Trials in Nashville, Tennessee

1 recruitingNashville, Tennessee

Showing 1–1 of 1 trials

Recruiting
Phase 1

A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)

B-cell Non Hodgkin LymphomaRefractory B-Cell Non-Hodgkin LymphomaRelapsed B-Cell Non Hodgkin Lymphoma
ADC Therapeutics S.A.200 enrolled42 locationsNCT04970901